dc.contributor.author |
Gourni, E |
en |
dc.contributor.author |
Bouziotis, P |
en |
dc.contributor.author |
Zikos, C |
en |
dc.contributor.author |
Loudos, G |
en |
dc.contributor.author |
Xanthopoulos, S |
en |
dc.contributor.author |
Fani, M |
en |
dc.contributor.author |
Archimandritis, SC |
en |
dc.contributor.author |
Varvarigou, AD |
en |
dc.date.accessioned |
2014-03-01T01:23:42Z |
|
dc.date.available |
2014-03-01T01:23:42Z |
|
dc.date.issued |
2006 |
en |
dc.identifier.issn |
0168-9002 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/17109 |
|
dc.subject |
99mTc |
en |
dc.subject |
Bombesin |
en |
dc.subject |
Gamma camera imaging |
en |
dc.subject |
Gastrin releasing peptide |
en |
dc.subject.classification |
Instruments & Instrumentation |
en |
dc.subject.classification |
Nuclear Science & Technology |
en |
dc.subject.classification |
Physics, Particles & Fields |
en |
dc.subject.classification |
Spectroscopy |
en |
dc.subject.other |
Biological organs |
en |
dc.subject.other |
Cells |
en |
dc.subject.other |
Derivatives |
en |
dc.subject.other |
Growth kinetics |
en |
dc.subject.other |
Synthesis (chemical) |
en |
dc.subject.other |
Tumors |
en |
dc.subject.other |
99mTc |
en |
dc.subject.other |
Bombesin |
en |
dc.subject.other |
Gamma camera imaging |
en |
dc.subject.other |
Gastrin releasing peptides |
en |
dc.subject.other |
Amino acids |
en |
dc.title |
Comparative in vivo evaluation of two novel 99mTc labelled bombesin derivatives |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1016/j.nima.2006.08.141 |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1016/j.nima.2006.08.141 |
en |
heal.language |
English |
en |
heal.publicationDate |
2006 |
en |
heal.abstract |
Bombesin (BN), a 14 amino acid peptide, is an analogue of human gastrin-releasing-peptide (GRP) that binds to GRP receptors (GRP-R) with high affinity and specificity. In addition to this physiological role, GRP, through its interaction with GRP-R, promotes tumour growth in a number of human cancer cell lines. The GRP receptors are over-expressed on a variety of human cancer cells. Aim of the present work is the study of two novels BN-like peptides, by investigating the radiochemical and radiopharmacological behaviour of their complexes with metals. The derivatives under study are: Gly-Gly-Cys-Aca-BN [2-14] where Aca: 6-amino-hexanoic acid. Pyroglutamic acid in the bombesin molecule has been replaced by the chemical group Gly-Gly-Cys-Aca, which bears an amino-acid combination capable of complexing a variety of radiometals. The other derivative under study is: Gly-Gly-Cys-Aca-BN [7-14]. This moiety of the peptide has been chosen because it has been proven to be a potent GRP agonist. The peptide derivatives were synthesized by SPPS, according to the Fmoc strategy and were identified by reverse phase high performance liquid chromatography (RP-HPLC). Radiolabelling with Tc-99m was performed via the precursor Tc-99m-gluconate. The stability of the radiolabelled species was examined with time. In vivo studies of the two Tc-99m-labelled derivatives were performed, comparatively, in normal mice, attention being focused on GRP receptor-bearing organs, and in experimentally induced prostate cancer models. Experimental tumours were imaged in a small field-of-view animal gamma camera. (c) 2006 Elsevier B.V. All rights reserved. |
en |
heal.publisher |
ELSEVIER SCIENCE BV |
en |
heal.journalName |
Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment |
en |
dc.identifier.doi |
10.1016/j.nima.2006.08.141 |
en |
dc.identifier.isi |
ISI:000243241300080 |
en |
dc.identifier.volume |
569 |
en |
dc.identifier.issue |
2 SPEC. ISS. |
en |
dc.identifier.spage |
518 |
en |
dc.identifier.epage |
521 |
en |